You have 9 free searches left this month | for more free features.

Tucatinib

Showing 1 - 25 of 59

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HER2-positive Breast Cancer Trial (Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab))

Not yet recruiting
  • HER2-positive Breast Cancer
  • Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab)
  • (no location specified)
Jul 20, 2023

Metastatic Breast Cancer Trial in New York (Tucatinib)

Recruiting
  • Metastatic Breast Cancer
  • Tucatinib
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 26, 2023

Breast Cancer Trial (Tucatinib, Doxil)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Feb 17, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 2, 2023

HER2-positive Breast Cancer, LMD Trial (Tucatinib 150 MG, Trastuzumab, Capecitabine)

Not yet recruiting
  • HER2-positive Breast Cancer
  • LMD
  • Tucatinib 150 MG
  • +3 more
  • (no location specified)
Aug 24, 2023

Brain Metastases, HER2-positive Breast Cancer Trial (Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine)

Not yet recruiting
  • Brain Metastases
  • HER2-positive Breast Cancer
  • Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine
  • (no location specified)
Jan 10, 2023

Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)

Not yet recruiting
  • Breast Cancer Metastatic
  • Leptomeningeal Metastasis
  • Tucatinib Oral Tablet
  • +2 more
  • (no location specified)
Mar 23, 2023

Metastatic Solid Tumor, Brain Metastases Trial in Houston (Trastuzumab emtansine, Tucatinib)

Not yet recruiting
  • Metastatic Solid Tumor
  • Brain Metastases
  • Trastuzumab emtansine
  • Tucatinib
  • Houston, Texas
    M D Anderson Cancer Center
Dec 30, 2022

HER2-positive Metastatic Breast Cancer Trial in Aurora, Madison (Alpelisib, Tucatinib, Fulvestrant)

Recruiting
  • HER2-positive Metastatic Breast Cancer
  • Aurora, Colorado
  • +2 more
Dec 29, 2022

Breast Cancer Trial (Tucatinib, Eribulin, Trastuzumab)

Not yet recruiting
  • Breast Cancer
  • Tucatinib
  • +2 more
  • (no location specified)
Jul 12, 2022

Adenocarcinoma of the Rectum, Locally Advanced Rectal Adenocarcinoma, Rectal Adenocarcinoma Trial in United States (Trastuzumab,

Recruiting
  • Adenocarcinoma of the Rectum
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Los Angeles (Tucatinib, Pembrolizumab, Trastuzumab)

Withdrawn
  • Breast Cancer
  • +3 more
  • Tucatinib
  • +2 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jun 28, 2022

Metastatic HER2+ Advanced Breast Cancer, Breast Tumors, Gastric or Gastroesophageal Junction Adenocarcinoma (GEC) Trial in

Recruiting
  • Metastatic HER2+ Advanced Breast Cancer
  • +3 more
  • Tucatinib
  • Harbin, Heilongjiang, China
  • +4 more
Nov 15, 2022

Breast Cancer Stage IV Trial in Clackamas, Newberg, Portland (Tucatinib)

Recruiting
  • Breast Cancer Stage IV
  • Tucatinib
  • Clackamas, Oregon
  • +3 more
Jan 12, 2022

Tucatinib in Locally Advanced or Metastatic HER2-positive Breast

Recruiting
  • HER2-positive Breast Cancer
  • Essen, Northrhine-Westphalia, Germany
    Universitätsklinikum Essen, Innere Klinik (Tumorforschung)
May 30, 2022

Breast Cancer, HER2-positive Breast Cancer Trial in Australia (Tucatinib, Pembrolizumab, Trastuzumab)

Not yet recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Tucatinib
  • +3 more
  • Albury, New South Wales, Australia
  • +11 more
May 22, 2022

Breast Cancer Trial in United States (Tucatinib in Combination with Palbociclib and Letrozole)

Active, not recruiting
  • Breast Cancer
  • Tucatinib in Combination with Palbociclib and Letrozole
  • Tucson, Arizona
  • +5 more
Mar 8, 2022

Colorectal Tumors Trial in United States (tucatinib, trastuzumab, bevacizumab)

Recruiting
  • Colorectal Neoplasms
  • tucatinib
  • +7 more
  • Anaheim, California
  • +13 more
Aug 15, 2022

HER2-positive Metastatic Breast Cancer, Locally Advanced HER2 Positive Breast Carcinoma Trial in Spain (Tucatinib, Trastuzumab,

Not yet recruiting
  • HER2-positive Metastatic Breast Cancer
  • Locally Advanced HER2 Positive Breast Carcinoma
  • Tucatinib
  • +2 more
  • Cádiz, Andalucía, Spain
  • +17 more
Jan 16, 2023

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +5 more
  • Trastuzumab
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 31, 2023

Metastatic Breast Cancer With a Isolated Brain Progression Trial in France (Tucatinib, Pertuzumab, Trastuzumab)

Recruiting
  • Metastatic Breast Cancer With a Isolated Brain Progression
  • Tucatinib
  • +4 more
  • Angers, France
  • +33 more
Aug 10, 2022

HER2-positive Gastric Cancer Trial in United States (Cinrebafusp alfa (PRS-343) in combination with ramucirumab and paclitaxel,

Recruiting
  • HER2-positive Gastric Cancer
  • Cinrebafusp alfa (PRS-343) in combination with ramucirumab and paclitaxel
  • Cinrebafusp alfa (PRS-343) in combination with tucatinib
  • Santa Barbara, California
  • +3 more
Jan 14, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022